Sionna Therapeutics, Inc.
SION · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$20,278 | -$18,068 | -$16,482 | -$15,848 |
| Dep. & Amort. | $100 | $147 | $159 | $167 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3,306 | $2,840 | $2,094 | $1,064 |
| Change in WC | $1,899 | -$2,396 | -$1,853 | $3,136 |
| Other Non-Cash | -$257 | -$676 | -$206 | -$300 |
| Operating Cash Flow | -$15,230 | -$18,153 | -$16,288 | -$11,781 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$87 | $0 | -$86 | -$27 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$54,136 | -$56,416 | -$171,595 | -$7,200 |
| Inv. Sales/Matur. | $77,325 | $33,171 | $30,487 | $22,455 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $23,102 | -$23,245 | -$141,194 | $15,228 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1,974 | -$312 | $202,389 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | -$1,408 |
| Financing Cash Flow | $1,974 | -$312 | $202,389 | -$1,408 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $9,846 | -$41,710 | $44,907 | $2,039 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $40,985 | $83,657 | $38,750 | $36,711 |
| End Cash | $50,831 | $41,947 | $83,657 | $38,750 |
| Free Cash Flow | -$15,317 | -$18,153 | -$16,374 | -$11,808 |